Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
Sean E. George net worth and biography

Sean George Biography and Net Worth

CEO of Invitae
Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

What is Sean E. George's net worth?

The estimated net worth of Sean E. George is at least $1.89 million as of December 16th, 2022. Dr. George owns 743,840 shares of Invitae stock worth more than $1,889,354 as of January 28th. This net worth evaluation does not reflect any other assets that Dr. George may own. Learn More about Sean E. George's net worth.

How do I contact Sean E. George?

The corporate mailing address for Dr. George and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected] Learn More on Sean E. George's contact information.

Has Sean E. George been buying or selling shares of Invitae?

Sean E. George has not been actively trading shares of Invitae during the past quarter. Learn More on Sean E. George's trading history.

Who are Invitae's active insiders?

Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.

Are insiders buying or selling shares of Invitae?

During the last year, insiders at the medical research company sold shares 17 times. They sold a total of 244,158 shares worth more than $1,068,838.39. The most recent insider tranaction occured on December, 19th when Director Sean E George sold 11,163 shares worth more than $23,219.04. Insiders at Invitae own 1.1% of the company. Learn More about insider trades at Invitae.

Information on this page was last updated on 12/19/2022.

Sean E. George Insider Trading History at Invitae

See Full Table

Sean E. George Buying and Selling Activity at Invitae

This chart shows Sean E. George's buying and selling at Invitae by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Invitae Company Overview

Invitae logo
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $2.54
Low: $2.41
High: $2.62

50 Day Range

MA: $2.32
Low: $1.71
High: $2.97

2 Week Range

Now: $2.54
Low: $1.67
High: $12.04

Volume

8,224,415 shs

Average Volume

7,051,681 shs

Market Capitalization

$616.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.72
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.